Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening of Lipid Metabolism-Related Gene Diagnostic Signature for Patients With Dilated Cardiomyopathy

1 Apr 2022

Abstract excerpt

Background: Dilated cardiomyopathy (DCM) is characterized by enlarged ventricular dimensions and systolic dysfunction and poor prognosis. Myocardial lipid metabolism appears abnormal in DCM. However, the mechanism of lipid metabolism disorders in DCM remains unclear. Methods: A gene set variation analysis (GSVA) were performed to estimate pathway activity related to DCM progression. Three datasets and clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Disease and Adiposity
Share to Cardiovascular Function and Risk Factors
Share to Kruppel-like factors research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35433888
DOI: 10.3389/fcvm.2022.853468

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening of Lipid Metabolism-Related Gene Diagnostic Signature for Patients With Dilated CardiomyopathyPMID 35433888Read ↗

A Unique Glycerophospholipid Metabolism Profile of Dilated Cardiomyopathy with Predictive valueSemantic proximity Read ↗

Integrative plasma lipidomics and proteomics profiling to decipher potential biomarkers of dilated cardiomyopathySemantic proximity Read ↗

Multiomics Analysis of Transcriptome, Epigenome, and Genome Uncovers Putative Mechanisms for Dilated Cardiomyopathy.Semantic proximity Read ↗

Targeting lipid metabolism as a new therapeutic strategy for inherited cardiomyopathiesSemantic proximity Read ↗

Analysis of differentially expressed genes related to the development of diabetic cardiomyopathy in the myocardium of type-2 diabetic ratsSemantic proximity Read ↗

Identifying the Oxidative Stress-Related Diagnostic Biomarkers in Dilated Cardiomyopathy by Bioinformatics AnalysisSemantic proximity Read ↗

Identification of lipid metabolism-related biomarkers for diagnosis and molecular classification of atherosclerosisSemantic proximity Read ↗

Identification of potential biomarkers associated with dilated cardiomyopathy by bioinformatics analysisSemantic proximity Read ↗

Identification of important modules and biomarkers in diabetic cardiomyopathy based on WGCNA and LASSO analysisSemantic proximity Read ↗

Integrated genomic analysis defines molecular subgroups in dilated cardiomyopathy and identifies novel biomarkers based on machine learning methodsSemantic proximity Read ↗

Machine learning-based identification of key lipid metabolism-related genes and associated ceRNA networks in NAFLDSemantic proximity Read ↗

Identification of Potential Diagnostic Biomarkers and Biological Pathways in Hypertrophic Cardiomyopathy Based on Bioinformatics AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.